BRIEF-Akers Biosciences says Q3 revenue rose 10 pct to $675,800
November 15, 2017 at 07:05 AM EST
* Akers Biosciences Inc - Q3 gross margin reduced to 52% Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|